Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07815587

Ultrasound Assessment of Gluteal Muscle in Patients Receiving Depot Antipsychotics and Healthy Volunteers

This observational study will use ultrasound to assess the gluteal musculature in patients receiving depot antipsychotic medication and in healthy volunteers. The study aims to improve knowledge about anatomical conditions relevant to intramuscular depot injections.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adults receiving depot antipsychotic medication and able to provide informed consent.

Healthy volunteers: adults able to provide informed consent.

Exclusion criteria

  • Acute infections at the injection site
  • Previous surgery that makes ultrasound examination difficult

Treatment and study plan

Primary outcomes

  1. Ultrasound-based assessment of gluteal anatomy, including measurements relevant to identifying an appropriate intramuscular injection site.

    Time frame: At the ultrasound examination (single study visit).

    Primary outcome is skin muscle (gluteus) distanse in millimeter

Sponsors and collaborators

Lead sponsor

St. Olavs Hospital

Other

Collaborators

  • SINTEF Health Research

Registry information

Official study title

Ultrasound-Guided Assessment of Gluteal Muscle in Patients Receiving Depot Antipsychotics and Healthy Volunteers

Acronym: ULPSYK

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Sep 11, 2026
Registry last updated
Sep 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.